VISGENX, INC.

Profile

Company Names

VISGENX, INC.

Addresses

3210 MERRYFIELD ROW, SAN DIEGO, CA 92121

C/O COOLEY LLP, 4401 EASTGATE MALL, SAN DIEGO, CA 92121

Phone Numbers

4082035023

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$9,166,198.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-06-02 
$2,763,915.00 
$3,497,724.00 
$733,809.00 
Equity 
2
2020-05-11 
$5,747,283.00 
$5,747,283.00 
$0.00 
Equity 
1
2019-07-12 
$655,000.00 
$2,200,000.00 
$1,545,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ARTHUR 
 
BECKER 
DIRECTOR
VISGENX, INC.   |  AI PROTEINS, INC.   |  NEXTRNA THERAPEUTICS, INC.   |  CARGOMETRICS TECHNOLOGIES INC.   |  IPILL INC.
ERIC 
 
CARTER, PH.D., M.D. 
DIRECTOR
VISGENX, INC.
FRANK 
 
DOUGLAS 
DIRECTOR
VISGENX, INC.   |  IMMUNOCELLULAR THERAPEUTICS, LTD.
FRANK 
 
DOUGLAS, M.D., PH.D. 
DIRECTOR
VISGENX, INC.
MARTIN 
 
EMANUELE 
EXECUTIVE OFFICER, DIRECTOR
VISGENX, INC.
MARTIN 
 
EMANUELE, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
VISGENX, INC.
ELAINE 
 
HERON, PH.D. 
DIRECTOR
VISGENX, INC.
THOMAS 
 
MEIER, PH.D., M.D. 
DIRECTOR
VISGENX, INC.
WILLIAM 
 
PEDRANTI 
EXECUTIVE OFFICER, DIRECTOR
SCILEX PHARMACEUTICALS, INC   |  SCILEX PHARMACEUTICALS INC.   |  VISGENX, INC.
SANTOSH 
 
VETTICADEN 
EXECUTIVE OFFICER, DIRECTOR
AMPLYX PHARMACEUTICALS, INC.   |  VISGENX, INC.
SANTOSH 
 
VETTICADEN, M.D., PH.D., MBA 
EXECUTIVE OFFICER, DIRECTOR
VISGENX, INC.
SANTOSH 
 
VETTICADEN, PH.D., M.D. 
DIRECTOR
VISGENX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-02 
2020-08-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-11 
2020-05-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-11 
2019-07-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-07-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#